You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cenegermin

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Corneal Nerves After Treatment With Cenegermin

Recruiting
  • Neurotrophic Keratitis
  • Cenegermin Ophthalmic Solution [Oxervate]
  • Los Angeles, California
    University of California, Los Angeles
Oct 14, 2022

Corneal Disease, Neuropathy Trial in Boston (Cenegermin-Bkbj)

Withdrawn
  • Corneal Disease
  • Neuropathy
  • Boston, Massachusetts
    Tufts Medical Center
Jan 18, 2023

Dry Eye Syndrome Trial in Italy, United States (Oxervate, Vehicle)

Active, not recruiting
  • Dry Eye Syndrome
  • Glendale, California
  • +10 more
Feb 1, 2023

Neurotrophic Keratitis Trial in United States (cenegermin-bkbj)

Completed
  • Neurotrophic Keratitis
  • San Diego, California
  • +4 more
Apr 11, 2022

Dry Eye Syndrome Trial in Wien (rhNGF 20 µg/mL, rhNGF 4 µg/mL)

Completed
Has Results
  • Dry Eye Syndrome
  • rhNGF 20 µg/mL
  • rhNGF 4 µg/mL
  • Wien, Austria
    Department of Clinical Pharmacology
Dec 14, 2022

Dry Eye Trial in Italy, United States (Oxervate, Vehicle)

Active, not recruiting
  • Dry Eye
  • Glendale, California
  • +10 more
Oct 24, 2022

DEFENDO Long Term Follow-up Study in Stage 1 NK Patients

Not yet recruiting
  • Neurotrophic Keratitis
  • Cenegemin in the DEFENDO Study
  • San Diego, California
  • +2 more
Dec 12, 2022

Nerve Growth Factor for the Treatment of Cornea Disease

Completed
  • Neurotrophic Keratitis
  • Stanford, California
    Stanford University
Dec 10, 2021

Neurotrophic Ulcer Following Treatment With Oxervate

Recruiting
  • Neurotrophic Ulcer
  • +3 more
  • Cenegermin-Bkbj 0.002% Ophthalmic Solution [OXERVATE]
  • Manhasset, New York
    SightMD
May 3, 2022

Dry Eye Syndrome Trial in United States (rhNGF 20 µg/ml, rhNGF 20 µg/ml + vehicle, Vehicle)

Completed
Has Results
  • Dry Eye Syndrome
  • rhNGF 20 μg/ml
  • +2 more
  • Glendale, California
  • +11 more
Jan 13, 2022

Neurotrophic Keratitis Trial in United States (rhNGF 20µg/ml, Placebo)

Completed
Has Results
  • Neurotrophic Keratitis
  • rhNGF 20µg/ml
  • Placebo
  • Loma Linda, California
  • +11 more
Mar 31, 2022

Glaucoma Trial in Palo Alto (rhNGF, Vehicle)

Completed
Has Results
  • Glaucoma
  • Palo Alto, California
    Byers Eye Institute at Stanford University
Nov 24, 2020

Healthy Volunteers Trial in Cypress (rhNGF 20µg/mL, Placebo)

Completed
Has Results
  • Healthy Volunteers
  • rhNGF 20μg/mL
  • Placebo
  • Cypress, California
    WCCT Global
Jun 1, 2020

Renewal of Corneal Nerves Structure and Function in Neurotrophic

Completed
  • Neurotrophic Keratopathy
  • Cenegermin, recombinant human Nerve Growth Factor (rhNGF) eyedrops
  • Chieti, Italy
    Ophtalmology Clinic, G.d'Annunzio University
Mar 3, 2020

Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients

Recruiting
  • Ocular GVHD
    • Indianapolis, Indiana
      Glick Eye Institute - Indiana University
    Sep 2, 2021

    Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

    Not yet recruiting
    • Optic Pathway Glioma
    • Rome, Italy
      Catholic University, Policlinico A. Gemelli (Hospital)
    Feb 17, 2023

    Dry Eye Trial in Philadelphia (NGF, Vehicle)

    Completed
    Has Results
    • Dry Eye
    • Philadelphia, Pennsylvania
      Penn Dry Eye and Ocular Surface Center, University of Pennsylvan
    Jan 16, 2019